Markets

Market Nav

RATIO ANALYSIS

You can view the ratio analysis for the last 5 years.
Novelix Pharmaceuticals Ltd.
ParticularsMar 22Mar 21Mar 20Mar 19Mar 18
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
PER SHARE RATIOS     
      
Basic EPS (Rs.)-2.22-4.62-0.35-0.30-0.48
Diluted EPS (Rs.)-2.22-4.62-0.35-0.30-0.48
Cash EPS (Rs.)-2.48-4.36-0.080.07-0.13
Book Value[Excl.RevalReserv]/Share (Rs.)9.489.0913.7414.1014.29
Book Value[Incl.RevalReserv]/Share (Rs.)9.489.0913.7414.1014.29
Revenue From Operations / Share (Rs.)10.6311.4112.6512.9112.97
PBDIT / Share (Rs.)-2.49-4.260.110.260.24
PBIT / Share (Rs.)-2.62-4.52-0.120.01-0.04
PBT / Share (Rs.)-2.62-4.60-0.26-0.15-0.24
Net Profit / Share (Rs.)-2.61-4.62-0.31-0.18-0.42
NP After MI And SOA / Share (Rs.)-2.22-4.62-0.34-0.29-0.48
      
PROFITABILITY RATIOS     
      
PBDIT Margin (%)-23.46-37.380.882.081.91
PBIT Margin (%)-24.64-39.64-0.980.05-0.34
PBT Margin (%)-24.64-40.32-2.09-1.18-1.86
Net Profit Margin (%)-24.55-40.47-2.52-1.41-3.31
NP After MI And SOA Margin (%)-20.91-40.46-2.76-2.31-3.71
Return on Networth / Equity (%)-24.31-54.47-2.67-2.21-3.49
Return on Capital Employeed (%)-27.17-49.51-0.840.04-0.28
Return On Assets (%)-20.60-39.06-2.06-1.81-2.87
Long Term Debt / Equity (X)0.010.000.070.080.08
Total Debt / Equity (X)0.010.000.070.080.08
Asset Turnover Ratio (%)0.100.080.080.270.24
      
LIQUIDITY RATIOS     
      
Current Ratio (X)6.383.376.3010.8711.17
Quick Ratio (X)5.312.945.8010.0710.26
      
COVERAGE RATIOS     
      
Interest Coverage Ratio (%)0.00-54.510.791.681.25
Interest Coverage Ratio (Post Tax) (%)0.00-58.02-1.26-0.14-1.18
      
VALUATION RATIOS     
      
Enterprise Value (Cr.)4.723.901.756.907.15
EV / Net Operating Revenue (X)0.540.420.170.650.68
EV / EBITDA (X)-2.33-1.1319.2031.6335.58
MarketCap / Net Operating Revenue (X)0.830.590.150.540.58
Price / BV (X)0.970.790.140.510.54
Price / Net Operating Revenue (X)0.830.590.150.540.58
EarningsYield-0.24-0.68-0.17-0.04-0.06
ParticularsMar 22
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
  
PER SHARE RATIOS 
Basic EPS (Rs.)-2.22
Diluted EPS (Rs.)-2.22
Cash EPS (Rs.)-2.48
Book Value[Excl.RevalReserv]/Share (Rs.)9.48
Book Value[Incl.RevalReserv]/Share (Rs.)9.48
Revenue From Operations / Share (Rs.)10.63
PBDIT / Share (Rs.)-2.49
PBIT / Share (Rs.)-2.62
PBT / Share (Rs.)-2.62
Net Profit / Share (Rs.)-2.61
NP After MI And SOA / Share (Rs.)-2.22
PROFITABILITY RATIOS 
PBDIT Margin (%)-23.46
PBIT Margin (%)-24.64
PBT Margin (%)-24.64
Net Profit Margin (%)-24.55
NP After MI And SOA Margin (%)-20.91
Return on Networth / Equity (%)-24.31
Return on Capital Employeed (%)-27.17
Return On Assets (%)-20.60
Long Term Debt / Equity (X)0.01
Total Debt / Equity (X)0.01
Asset Turnover Ratio (%)0.10
LIQUIDITY RATIOS 
Current Ratio (X)6.38
Quick Ratio (X)5.31
COVERAGE RATIOS 
Interest Coverage Ratio (%)0.00
Interest Coverage Ratio (Post Tax) (%)0.00
VALUATION RATIOS 
Enterprise Value (Cr.)4.72
EV / Net Operating Revenue (X)0.54
EV / EBITDA (X)-2.33
MarketCap / Net Operating Revenue (X)0.83
Price / BV (X)0.97
Price / Net Operating Revenue (X)0.83
EarningsYield-0.24